Key Takeaway: Allogene Therapeutics has scheduled its Second Quarter 2026 Conference Call for August 12, 2026, at 5:00 PM EDT. The call will provide updates and insights into the company's performance during the second quarter. Interested parties can access the call via a webcast.
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+57%
120-day peak, hindsight
Typical move
7%
average across 3 past catalysts
Cash runway
~60 mo
Minimal dilution risk
Lead asset
ALLO-501
Phase 1 · Relapsed/Refractory Large B Cell Lymphoma
Full Press Release Details
Contact Us
Careers
SHARE
Event Details
The Allogene Therapeutics Second Quarter 2026 Conference Call